日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hypoxia-driven remodeling of SELENOP(+) macrophages shapes T cell dynamics and promotes ovarian cancer metastasis.

缺氧驱动的 SELENOP(+) 巨噬细胞重塑塑造 T 细胞动力学并促进卵巢癌转移。

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial

索玛鲁肽与肥胖合并心血管疾病患者的住院情况:SELECT随机临床试验的探索性分析

Nicholls, Stephen J; Ryan, Donna H; Deanfield, John; Ferreira, Daniel; Lang, Chim C; Lincoff, A Michael; Lingvay, Ildiko; Lübker, Christopher; Terns, Paula Pérez; Rasmussen, Søren; Stensen, Signe; Weeke, Peter E; Kahn, Steven E

Novel Homo-SELEX for selecting universal aptamer for cross-species kidney injury biomarker KIM-1 in muti-scenario situ imaging

一种用于筛选通用适体的新型同源SELEX方法,可用于多场景原位成像中的跨物种肾损伤生物标志物KIM-1。

Yang, He; Du, Zaihui; Zhu, Longjiao; Guo, Haiying; Che, Xu; Cao, Qiaona; Zhu, Yuyu; He, Xiaoyun; Dong, Yulan; Huang, Kunlun; Xu, Wentao

Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan

针对既往接受过治疗且伴有腹膜播散的胃癌患者,采用溶剂型或白蛋白结合型紫杉醇联合雷莫芦单抗治疗,并进行预先设定的生物标志物分析(P-SELECT/WJOG10617G):一项在日本开展的随机II期临床试验

Hirata, Kenro; Hamamoto, Yasuo; Shoji, Hirokazu; Hara, Hiroki; Kondoh, Chihiro; Yasui, Hisateru; Kajiwara, Takeshi; Baba, Eishi; Ando, Takayuki; Sugimoto, Naotoshi; Kawakami, Hisato; Katsuya, Hiroo; Nagase, Michitaka; Yamamoto, Yoshiyuki; Yoshimura, Kenichi; Ando, Masahiko; Imamura, Chiyo K; Yamazaki, Kentaro; Hironaka, Shuichi; Muro, Kei

Identifying a cancer therapeutic target: Cell-SELEX identifies a membrane protein for aptamer-mediated growth suppression

确定癌症治疗靶点:Cell-SELEX 鉴定出一种膜蛋白,可用于适体介导的生长抑制

Cui, Wei; Xiao, Hang; Wen, Xiaohong; Li, Chen; Bao, Suxia; Zeng, Jiahao; Li, Yangbing; Qiao, Yan; Wang, Kemin; Wang, Honghui; Huang, Jin; Guo, Qiuping

Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled Trial

经动脉化疗栓塞联合索拉非尼对比单用索拉非尼治疗晚期肝细胞癌(SELECT):一项多中心、3期、随机、对照试验

Zhao, Yan; Bai, Wei; Ding, Rong; You, Nan; Zheng, Lin; Li, Lei; Wu, Jianbing; Zhang, Peng; Huang, Wukui; Zhang, Hui; Zhang, Yongjin; Zhu, Diwen; Li, Haiping; Xia, Dongdong; Yuan, Jie; Li, Xiaomei; Wang, Zhengyu; Luo, Bohan; Guo, Wengang; Yin, Zhanxin; Mu, Wei; Huang, Ming; Li, Jing; Ren, Weixin; Fan, Daiming; Lv, Yong; Han, Guohong

Affinity Maturation of a Fentanyl Aptamer by Motif-SELEX

利用基序SELEX技术对芬太尼适体进行亲和力成熟。

Alkhamis, Obtin; Canoura, Juan; Castro, Gabriel; Byrd, Caleb; Bryant, Alexandra; Yu, Haixiang; Xiao, Yi

Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma

Cell-SELEX 筛选出一种 DNA 适体,用于胆管癌体内高选择性 siRNA 递送。

Wilbanks, Brandon A; Kabashima, Ayano; Ozmert, Enis H; Sample, Jack W; Driscoll, Julia; Carlson, Danielle M; Doherty, Caroline D; Kimball, Brooke; Millender, Jayla; Yan, Irene K; Nishi, Hidemi; Gondaliya, Piyush; Pearson, Keenan S; Gores, Gregory J; Patel, Tushar; Maher, L James 3rd; Smoot, Rory L

A 12-Week, Open-Label, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Lemborexant in Patients with Insomnia Comorbid with Depressive Episodes (SELENADE)

一项为期 12 周、开放标签、多中心试点研究,旨在评估 Lemborexant 治疗伴有抑郁发作的失眠患者的疗效和安全性 (SELENADE)

Takaesu, Yoshikazu; Muraoka, Hiroyuki; Takeshima, Masahiro; Kato, Masaki; Hirakawa, Hirofumi; Hori, Hikaru; Inada, Ken; Sakurai, Hitoshi; Ozone, Motohiro; Koshikawa, Yosuke; Murao, Tomohiko; Terao, Takeshi; Watanabe, Koichiro; Yokoyama, Haruka; Koebisu, Michinori; Kawatsu, Yuka; Takekita, Yoshiteru

High-Throughput Sequencing and SELEX-Based Protocol for Selecting Aptamers Against Potato Spindle Tuber Viroid

用于筛选抗马铃薯纺锤块茎类病毒适体的高通量测序和基于SELEX的方案

Kaponi, Maria S; Sano, Teruo; Naoi, Takashi; Kashiwagi, Akiko